Evidence map›Paper›PMID 42373960›Full record

ArticleBrain imaging and behavior2026

Prediction modeling in transdiagnostic risk: results from the PROCAN study.

Mohammed K Shakeel, Zeyad Abouyoussef, Paul D Metzak, Roberto Souza, Xiangyu Long, Mike Lasby, Signe Bray, Benjamin I Goldstein, Glenda MacQueen, JianLi Wang and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Brain imaging and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Mohammed K ShakeelDepartment of Psychiatry, Hotchkiss Brain Institute, University of Calgary, Mathison Centre, 3280 Hospital Dr NW, Calgary, AB, T2N 4Z6, Canada. mohammed.kalathil@ucalgary.ca.
Zeyad AbouyoussefDepartment of Biomedical Engineering, University of Calgary, Calgary, AB, Canada.
Paul D MetzakDepartment of Psychiatry, Hotchkiss Brain Institute, University of Calgary, Mathison Centre, 3280 Hospital Dr NW, Calgary, AB, T2N 4Z6, Canada.
Roberto SouzaElectrical and Software Engineering, University of Calgary, Calgary, AB, Canada.
Xiangyu LongDepartment of Radiology, University of Calgary, Calgary, AB, Canada.
Mike LasbyDepartment of Biomedical Engineering, University of Calgary, Calgary, AB, Canada.
Signe BrayDepartment of Radiology, University of Calgary, Calgary, AB, Canada.
Benjamin I GoldsteinCentre for Youth Bipolar Disorder, Center for Addiction and Mental Health, Toronto, ON, Canada.
Glenda MacQueenDepartment of Psychiatry, Hotchkiss Brain Institute, University of Calgary, Mathison Centre, 3280 Hospital Dr NW, Calgary, AB, T2N 4Z6, Canada.
JianLi WangDepartment of Community Health and Epidemiology, Faculty of Medicine, Dalhousie University, Halifax, NS, Canada.
Sidney H KennedyDepartment of Psychiatry, University Health Network, Toronto, ON, Canada.
Jean AddingtonDepartment of Psychiatry, Hotchkiss Brain Institute, University of Calgary, Mathison Centre, 3280 Hospital Dr NW, Calgary, AB, T2N 4Z6, Canada.
Catherine LebelDepartment of Radiology, University of Calgary, Calgary, AB, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Identifying biomarkers for serious mental illnesses (SMI) has significant implications for early intervention and prevention. The current study uses machine learning to build a model of risk prediction and transition based on multi-modal neuroimaging, clinical, and behavioral data from youth at transdiagnostic risk. Participants aged 12-25 were recruited at two sites in Canada, and followed for 4 years. Symptom severity was measured using the Scale of Psychosis-Risk Symptoms (SOPS) and K10 Distress Scale, and a range of cognitive and behavioral measures were collected, as well as magnetic resonance imaging (MRI) data. Participants were assigned to one of 5 groups: healthy controls (HC; n = 42), familial risk (stage 0; n = 40), mild symptoms (stage 1a; n = 48), attenuated syndromes (stage 1b; n = 82), or discrete disorder (transition; n = 31). Constrained spherical deconvolution was used to generate whole brain tractography maps from diffusion MRI, which were then used to calculate connectivity matrices for graph theory analysis. Graph theory was also used to analyze correlations of functional MRI signal between pairs of brain regions. All measures were evaluated in a model to predict transition between groups. Random Forest analysis identified diffusion MRI-derived nodal metrics of betweenness centrality in the angular gyrus, inferior temporal gyrus, amygdala and calcarine fissure as potential features which can discriminate between the groups. Additionally, SOPS and K10 Distress Scales were useful behavioral predictors of transdiagnostic risk. Our findings show that combining neuroimaging with clinical characteristics may result in a promising predictive model for transdiagnostic risk and transition to SMI.

Indexed as

BrainMental DisordersAdolescentAdultCanadaChildDiffusion Tensor ImagingFemaleHumansMachine LearningMagnetic Resonance ImagingMalePredictive Learning ModelsPsychotic DisordersRandom ForestYoung AdultBetweenness centralityConnectomeMachine learningPROCANRandom ForestTransdiagnostic risk

Identifiers

PMID42373960

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.